EXOZNasdaq

EXOZYMES INC.

Healthcare·Healthcare·Pre-clinical·Monrovia, CA, United States

EXOZYMES INC. (EXOZ): 2 pipeline candidates · ~3 mo cash runway. Updated within the last hour.

3.7/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway0.9

3.2 months

Financial Health7.6

D/E 1.63 · 0% dilution

Pipeline Maturity2.0

Lead: Preclinical

Pipeline Breadth4.6

2 candidates

Catalyst MomentumN/A

N/A

Insider Signal3.6

0 buys · 2 sells (180d)

A transparent, data-derived signal for EXOZYMES INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$62.3M

Cash

$1.4M

Quarterly Burn

$1.5M

Runway

3.2 mo

Revenue

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Sep 2026
Today~7 mo out
Catalyst within runway

Pipeline (2 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

5

Total value held

$628K

HolderSharesValue
vanguard capital management llc44,380$333K
geode capital management, llc21,891$164K
vanguard fiduciary trust co9,426$71K
blackrock, inc.6,797$51K
morgan stanley1,250$9K
·CEO: Mr. Michael Heltzen

Frequently asked questions

How many drug candidates are in EXOZYMES INC.'s pipeline?

EXOZYMES INC. (EXOZ) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is EXOZYMES INC.'s lead drug candidate?

EXOZYMES INC.'s most advanced tracked candidate is isobutanol (Preclinical) for Sustainable Aviation Fuel (SAF) and other sustainable biofuels and industrial chemical applications.

What is EXOZYMES INC.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, EXOZYMES INC. has approximately 3.2 months of cash runway.

What is EXOZYMES INC.'s market capitalization?

EXOZYMES INC.'s market capitalization is approximately $62.3M.

Who is the CEO of EXOZYMES INC.?

Mr. Michael Heltzen is the chief executive officer of EXOZYMES INC. (EXOZ).

Get the full picture on EXOZYMES INC.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.